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The echoendoscopic biliary drainage is an option to treat obstructive jaundices when ERCP drainage fails. These procedures
compose alternative methods to the side of surgery and percutaneous transhepatic biliary drainage, and it was only possible
by the continuous development and improvement of echoendoscopes and accessories. The development of linear setorial array
echoendoscopes in early 1990 brought a new approach to diagnostic and therapeutic dimenion on echoendoscopy capabilities,
opening the possibility to perform punction over direct ultrasonographic view. Despite of the high success rate and low morbidity
of biliary drainage obtained by ERCP, diﬃculty could be found at the presence of stent tumor ingrown, tumor gut compression,
periampulary diverticula, and anatomic variation. The echoendoscopic technique starts performing punction and contrast of the
left biliary tree. When performed from gastric wall, the access is made through hepatic segment III. From duodenum, direct
common bile duct punction. Dilatation is required before stent introduction, and a plastic or metallic stent is introduced. This
phraseshouldbereplacedby:diathermicdilatationofthepuncturingtractisrequiredusinga6Fcystostome.Thetechnicalsuccess
of hepaticogastrostomy is near 98%, and complications are present in 36%: pneumoperitoneum, choleperitoneum, infection, and
stent disfunction. To prevent bile leakage, we have used the 2 stent techniques, the ﬁrst stent introduced was a long uncovered
metallic stent (8 or 10cm), and inside this ﬁrst stent a second fully covered stent of 6cm was delivered to bridge the bile duct
and the stomach. Choledochoduodenostomy overall success rate is 92% and described complications include, in frequency order,
pneumoperitoneum and focal bile peritonitis, present in 19%. By the last 10 years, the technique was especially performed in
reference centers, by ERCP experienced groups, and this seems to be a general guideline to safer procedure execution.
1.Introduction
Endoscopic biliary stenting is the most common method to
treat obstructive jaundice. But in 3–12% of cases, selective
cannulation of the major papilla failed and surgery or per-
cutaneous biliary drainage is required. But percutaneous
drainage needed dilated intrahepatic biliary ducts and the
rate of complications reaches 25–30% of cases including per-
itoneal bleeding. A new technique of biliary drainage using
EUS and EUS-guided puncture of the bile duct (common
bile duct or left hepatic duct) is now possible.
Using EUS guidance and dedicated accessories it’s now
possible to create biliodigestive anastomosis.
T h ea i mo ft h i sp a p e ri s :
(1) to describe the material needed for such procedures,
(2) to describe the technique of biliary drainage under
EUS guidance,
(3) to describe the place today of these techniques in
comparison with ERCP.
2.Material
2.1. Interventional Echoendoscopes. Around 1990, the Pen-
tax-Corporation developed an electronic convex curved
linear array echoendoscope (FG32UA) with an imaging
plane in the long axis of the device that overlaps with the
instrumentation plane. This echoendoscope, equipped with
a2.0mmworkingchannel,enabledﬁne-needlebiopsyunder
EUSguidance.However,therelativelysmallworkingchannel
of the FG 32UA was a drawback for pseudocyst drainage
since it necessitated the exchange of the echoendoscope
for a therapeutic duodenoscope to insert either a stent or
nasocystic drain. To enable stent placement using an ech-
oendoscope, the EUS interventional echoendoscopes (FG2 Gastroenterology Research and Practice
Figure 1: 6F cystostome (Endoﬂex company).
38X,EG38UT,andEG3870UTK)weredevelopedbyPentax-
Hitachi.TheFG38Xhasaworkingchannelof3.2mm,which
allows the insertion of a 8.5F stent or nasocystic drain and
the EG38UT and EG3870UTK have a larger working channel
of 3.8mm with an elevator allowing the placement of a 10F
stent [1, 2].
The Olympus Corporation has also developed convex
array echoendoscopes. The GF UC 30P has a biopsy channel
of 2.8mm, which enables the placement of a 7-french stent
or nasocystic catheter, and the instrument is equipped with
an elevator. A new prototype, the GF UCT 30, has a larger
working-channel of 3.7mm allowing the placement of 10-
french stent. The main drawback of convex linear array
echoendoscopesisthemorelimitedimagingﬁeld(120◦ using
the Pentax and 180◦ using the Olympus) produced by an
electronic transducer. These instruments are coupled with
the Aloka processor or with a smaller processor (Suzie).
2.2. Needles and Accessories for Drainage. Some authors have
used needle knife catheters, but the needle can be diﬃcult to
visualize endosonographically. The “Zimmon” needle-knife
(Wilson-Cook Corporation, Winston Salem, NC, USA) has
a large gauge needle that is easier to visualize. Diathermy is
usually required to penetrate the cyst [3]( Figure 1).
A standard endosonography ﬁne needle aspiration
(FNA) needle is well visualized sonographically and can
be used for pseudocyst puncture. The drawback of this
needle is the small caliber (22 or 23G) that will accept
only a 0.018-inch guidewire. Using a 19G FNA needle
(Wilson-Cook Corporation), a 0.0035-inch guidewire can
be inserted through the needle into the dilated bile duct.
Wilson Cook Corporation has recently developed a “new
access needle”; However, one of the main problems during
thesenewtechniquesofhepaticogastrostomy,isthediﬃculty
manipulating the wire guide through the 19-gauge EUS
needle. The main trouble was the “stripping” of the coating
of the wire, which in turn created a risk of leaving a part of
the wire coating in the patient and also the impossibility to
Figure 2: Echotip “ACCESS NEEDLE” Cook company.
continue the procedure and to insert the stent. To solve this
problem, we worked with Cook Medical to design a special
needle called the EchoTip Access Needle∗ (Figure 2). This
needleisoriginalbecausethestyletissharpanditisrelatively
easy to insert the needle into the bile duct or the pancreatic
duct or a pseudocyst. When the stylet is withdrawn, the
needle left in place is smooth and the manipulation of the
wire guide is easy and the device is designed to decrease the
possibility of the wire stripping.
3. EUS-GuidedRendez-Vous Technique
After puncture of the left hepatic biliary system (see above)
using a 19-gauges needle (Echo−1−19; Cook Endoscopy),
a 0.035-inch hydrophilic guidewire (Tracer Metro Direct,
Cook Endoscopy or Jagwire, Boston scientiﬁc, Paris, France)
was inserted into the biliary duct and then rolled up inside
the duodenum. Then, echoendoscope was gently withdrawn
leaving the guidewire in place. Afterwards, a duodenoscope
was inserted in parallel of the guidewire and placed in the
third duodenum, allowing retrograde approach. Guidewire
was then catched with standard snare through the working
channel and after over-the-wire biliary sphincteromy, stones
r e m o v a lo rs t e n tp l a c e m e n tc o u l db ea c h i e v ea su s u a l l y .
4.EUS-Choledocoduodenostomy
A 19-G needle (EchoTip; Wilson-Cook) is inserted trans-
duodenally into the bile duct under EUS guidance. Bile is
aspirated and contrast medium is injected into the bile duct
for cholangiography. A 450-cm long, 0.035-inch guidewire is
inserted into through the 19-G needle into the bile duct. The
choledochoduodenal ﬁstula is dilated using a biliary catheter
for dilation (Soehendra biliary dilator; Wilson-Cook), or aGastroenterology Research and Practice 3
6F cystostome (Endoﬂex, company). A 7 Fr to 10 Fr biliary
plastic stent or a covered self-expandable metallic stent is
placed through the choledochoduodenostomy site into the
extrahepatic bile duct.
5. TechniqueofLeftHepaticogastrostomyunder
EUSGuidance(HGE)(Figure3)
EUS-guided hepaticogastrostomy was ﬁrst reported by
Burmester [4] in 2003. The technique is also basically
similar to EUS-guided drainage of pancreatic pseudocysts.
By using an interventional echoendoscope, the dilated left
hepaticduct(segmentIII)waswellvisualized.HGEwasthen
performed under combined ﬂuoroscopic and ultrasound
guidance, with the tip of the echoendoscope positioned such
that the inﬂated balloon was in the middle part of the small
curvature of the stomach. A needle (19G, EchoTip Access
Needle, Cook Ireland Ltd., Limerick, Ireland) was inserted
transgastricallyintothedistalpartofthelefthepaticductand
contrastmediumwasinjected.Opaciﬁcationdemonstrateda
dilated biliary ducts to the complete obstruction. The needle
wasexchangedoveraguidewire(0.02-inchdiameter,Terumo
Europe, Leuven, Belgium) for a 6.5F diathermic sheath (pro-
totypeCysto-Gastroset,EndoFlex,Voerde,Germany),which
was then used to enlarge the channel between the stomach
andthelefthepaticduct.Thesheathwasintroducedbyusing
cuttingcurrent.Afterexchangeoveraguidewire(TFE-coated
0.035-inch diameter, Cook Europe, Bjaeverskov, Denmark),
a 8.5F, 8-cm—long hepatico-gastric stent) or a covered
metallic expandable stent (Boston-scientiﬁc, 8cm length)
waspositioned.As observedbyﬂuoroscopy,contrastemptied
from the stent into the stomach. To prevent bile leakage
you can leave through the metallic stent a 6 or 7F naso-
biliary drain in aspiration during 48 hours. More recently
we decided to combine an uncovered stent and a covered
stent inserted into. Among these, hepaticogastrostomy was
sometimescombinedwithplacementofanadditionalmetal-
lic stent bridging the distal stricture.
6. Place of the Bilio-DigestiveAnastomosis
Guidedby EUSinComparison with ERCP
ERCP is still today the Gold Standard technique for the
drainage of an obstructive jaundice due to a pancreatic
cancer. Success rate of biliary stenting using ERCP is around
80–85% but sometime ERCP failed to cannulate selectively
the papilla or failed to reach the papilla in case of duodenal
obstruction. These new techniques of biliary drainage using
EUS guidance could be an alternative to percutaneous
procedures or to Surgery.
The problem with the percutaneous techniques of biliary
drainage is the high rate of complication (bleeding, peri-
toneal bile leakage) around 20–30% of the cases and the
morbidity and the mortality of Surgery for such palliative
procedures are, respectively, of 35–50% and 10–15%.
For probably, these new techniques of biliary drainages
will be in the future an alternative to Surgery and percuta-
neous biliary drainage.
To date, 120 patients with EUS-guided bile duct drainage
have been reported in thirteen studies (Table 1). 19-gauge
or 22-gauge ﬁne needles or ﬁne needles followed by needle
knife or cystotome were used for puncturing intrahepatic
bile ducts in all of the patients. Hepaticogastrostomy was
successful in all but two cases (49/51, 96%). Various types of
stents, including plastic stents, uncovered MS, and covered
MS were used for the drainage. Once the stents were placed,
all but one patient (48/49, 98%) had successful resolution
of obstructive jaundice. The rate of procedurerelated early
complicationswas19%(5mildand5severe)withonedeath:
1 case of ileus probably due to the use of morphine during
anesthesia, 1 case of bilioma, and 2 cases of cholangitis. Stent
migration has been reported as a late complication in one
case. Kahaleh et al. described that the advantages of EUS-
guided hepaticogastrostomy over percutaneous transhepatic
drainage included puncture of the biliary tree with real-
time US when using color-Doppler information to limit
the possibility of vascular injury, the lack of ascites in the
interventional ﬁeld when present in the peritoneum, and
the lack of an external drain. And based on their exper-
ience, they also pointed out the extrahepatic approach has
a greater chance of complication than the intrahepatic
approach.Itoietal.reportedthelimitationsofthistechnique
as follows, (i) nonapposed gastric wall and the left liver
lobe, with a certain displacement between the puncture site
of the gastric wall and intrahepatic bile duct, resulting in
possibility of procedure failure. (ii) risk of mediastinitis with
a transesophageal approach, (iii) diﬃculty of puncture in
case of liver cirrhosis, (iv) risk of injuring the portal vein and
(v) necessitating the use of small-caliber stents or MS with a
small-diameter delivery device [17].
From a clinical standpoint, however, the most relevant
technical choice appears to be the type of stent. As detailed
in Table 1, 7 to 8.5 plastic stents were placed in 46% of
cases, whereas uncovered, partially covered or fully covered
SEMS were placed initially in 54%. It is diﬃcult to draw
signiﬁcant conclusions from the published reports, since no
formal comparisons have been made between the two types
of stents. SEMS are appealing for three reasons. First, upon
full expansion SEMS eﬀectively seal the puncture/dilation
tract, which would in theory prevent leakage. Secondly,
their larger diameter provides better long-term patency,
which would decrease the need for stent revisions. Finally,
if dysfunction by ingrowth or clogging occurs, management
is somewhat less challenging than with plastic stents, since a
new stent (plastic or SEMS) can easily be inserted through
the occluded SEMS in place. In contrast, exchanging a
clogged plastic transmural stent usually requires over-the-
wire replacement, because free-hand removal involves the
risk of track disruption with subsequent guidewire passage
into the peritoneum, hence requiring repeat EUSBD if
drainage is to be reestablished [18]. These presumed ad-
vantages of SEMS must be balanced against the fact that
transmural SEMS insertion and deployment are somewhat
more demanding than they are at ERCP. In particular, the
serious risk of foreshortening and bile peritonitis should be
prevented with careful attention to details [15].4 Gastroenterology Research and Practice
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Figure 3: Hepaticogastrostomy performed after ERCP failed to drain the left hepatic lobe in patient with a Klatskin Tumor.
Table 1: Summary of the published literature on EUS-HG and related transmural intrahepatic EUSBD.
Author/year/ref n Total n IH-transmural Success Complications Initial stent
EUSBD EUSHG nonHG technical Clinical n Type Plastic SEMS
Burmester et al. [4] 2003 4 1 1 2 2 0 — 2 0
P¨ usp¨ ok et al. [5] 2005 6 0 1 1 1 0 — 1 0
Artifon et al. [6] 2007 1 1 0 1 1 0 — 0 1
Bories et al. [7] 2007 11 11 0 10 10 4 2 cholangitis, 1
ileus, 1 biloma 73
Will et al. [8] 2007 8 4 4 7 6 2 1 cholangitis, 1
pain 25
Chopin-Laly et al. [9] 2004 1 1 0 1 1 0 — 0 1
Iglesias-Garc´ ıa et al. [10]
2008 1 1 011 0 — N SN S
Horaguchi et al. [11] 2009 16 5 2 7 6 1 Cholangitis 7 0
Maranki et al. [12] 2009 49 3 0 3 3 0 — 3 0
Park et al. [13] 2009 14 8 1 9 9 2 Pneumo 0 9
Park et al. [14] 2010 5 5 0 5 5 0 — 0 5
Martins et al. [15] 2010 1 1 0 1 0 1 Peritonitis and
death 01
Eum et al. [16] 2010 3 1 0 1 1 0 — 0 1
Total 120 42 9 49 46 10 5 mild/5 severe 22 26
We reported recently our experience on 38 patients [19]
(F = 20, Mean age = 66.5yrs, (38–93yrs)) were referred
for management of biliary disorders: benign disease in 11
(iatrogenic stenosis = 8, chronic pancreatitis = 1, ﬁstula =
1, bile duct dilation = 1) and malignant in 27 (pancreatic
cancer = 10, cholangiocarcinoma = 10, other = 7). EUS
approach was chosen after failure of ERCP (n = 9),
impossibility to reach papilla (duodenal strictures = 6, post-
surgical anatomy = 9) or incomplete left bile duct drainage
(n = 14). All procedures were realized using therapeutic
echoendoscope, and ﬂuoroscopic guidance. EUS proce-
dures were performed using transgastric approach. Stents
were placed transpapillary (transpapillary stent insertion),
between the stomach and the left liver lobe to keep the
ﬁstula open (hepaticogastrostomy) or both. 41 EUS-guided
biliary procedures were realized. Choleperitoneum occurred
in 1 casen treated medically. 36 transgastric approaches were
performed in 35 patients with technical success in 97%. All
stents placed under EUS guidance were clinically eﬃcient.
Complicationsoccurredin25%(n=9,choleperitoneum = 5,Gastroenterology Research and Practice 5
stent migration = 3, liver abscess = 1). All complications were
managed conservatively. 1 patient died secondary to severe
choleperitoneum.
7. Conclusion
EUS-guided biliary management is useful in case of failure
of ERCP with a high rate of technical success and clinical
eﬃcacy. Morbidity rate is high during biliary drainage
requiringexperiencedteam.Insummary.EUS-guidedbiliary
procedure open a new way to achieve biliary drainage, com-
plementary to percutaneous approach. Hepaticogastrostomy
is feasible providing high success rate. Nevertheless morbid-
ity rate is still elevated. Further technical improvements are
therefore mandatory to reduces a number of adverse events.
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